Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Celgene may purchase $4.9M in additional shares of Globelmmune
The Fly on the Wall
Monday, August 20, 2012 - 10:28am
tags:
Celgene, GlobeImmune, M&A
Dendreon Provenge Sales Wobbling
Seeking Alpha
Monday, August 20, 2012 - 10:23am
tags:
prostage cancer, Dendreon, Provenge
Biostar Pharmaceuticals receives Army New Drug Certificate in China for Zushima spray
Yahoo/Fly on the Wall
Monday, August 20, 2012 - 10:21am
tags:
Biostar Pharmaceuticals, Zushima, China
Is The Healthcare Sector In A Bright Spot?
Seeking Alpha
Sunday, August 19, 2012 - 11:39am
tags:
Merck, Pfizer, generics, Teva Pharmaceuticals
This Fast Growing, Speculative $3 Medtech Stock Has Strong Upside And Insider Buying
Seeking Alpha
Sunday, August 19, 2012 - 11:34am
tags:
Unilife
Amgen: When Buybacks Work
Seeking Alpha
Sunday, August 19, 2012 - 11:33am
tags:
Amgen
3 Drug Companies That Want to Lose
Motley Fool
Sunday, August 19, 2012 - 11:32am
tags:
Arena, Vivus, Orexigen, obesity, weight loss, Belviq, Qsymia, Contrave, Empatic
5 Pharmaceutical Companies With Insider Buying During August 14-16
Seeking Alpha
Sunday, August 19, 2012 - 11:30am
tags:
Clovis Oncology, Depomed, Inovio, Furiex Pharmaceuticals, OncoGenex
Guilt by Association = 30% Slaughter?
Motley Fool
Sunday, August 19, 2012 - 11:27am
tags:
IDX184, hepatitis C, Idenix, GS-7977, Gilead Sciences, Vertex Pharmaceuticals
Hepatitis C testing may lift Vertex’s market
The Boston Globe, MA
Saturday, August 18, 2012 - 4:21pm
tags:
hepatitis C, Vertex, Incivek
BioSante Pharmaceuticals to Raise $3,475,000 in Registered Direct Offering
Enhanced Online News
Saturday, August 18, 2012 - 4:19pm
tags:
BioSante
Watson Pharma Sues FDA
Zacks
Saturday, August 18, 2012 - 4:18pm
tags:
Watson Pharmaceuticals, Actos, generics
HgCapital sells Mercury Pharma
The Deal
Saturday, August 18, 2012 - 4:15pm
tags:
Mercury Pharma
Bitter pill
Business Standard, India
Saturday, August 18, 2012 - 4:13pm
tags:
generics
Generic Market Overview: Standing at the Top of the Patent Cliff
Pharmacy Times
Saturday, August 18, 2012 - 4:12pm
tags:
generics
Pfizer, Hospira likely shoppers for Indian injectables star Agila
Fierce Pharma
Saturday, August 18, 2012 - 4:08pm
tags:
Pfizer, Hospira, Agila, Strides Arcolab
Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
PharmaLive
Saturday, August 18, 2012 - 4:07pm
tags:
Lexicon Pharmaceuticals, LX2931, rheumatoid arthritis, LX7101, glaucoma
6 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, August 18, 2012 - 4:05pm
tags:
Allergan, XenoPort, SciClone Pharmaceuticals, Acura Pharmaceuticals, Sucampo, Cumberland
AstraZeneca Wins This Summer's Pharma Acquisition Spree
Seeking Alpha
Saturday, August 18, 2012 - 4:03pm
tags:
AstraZeneca
Takeda's Actos era ends with generic launches
Fierce Pharma
Saturday, August 18, 2012 - 4:02pm
tags:
Takeda, Actos, diabetes, type 2 diabetes, generics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.